EnVVeno Medical Net Worth
EnVVeno Medical Net Worth Breakdown | NVNO |
EnVVeno Medical Net Worth Analysis
EnVVeno Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including EnVVeno Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of EnVVeno Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform EnVVeno Medical's net worth analysis. One common approach is to calculate EnVVeno Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares EnVVeno Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing EnVVeno Medical's net worth. This approach calculates the present value of EnVVeno Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of EnVVeno Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate EnVVeno Medical's net worth. This involves comparing EnVVeno Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into EnVVeno Medical's net worth relative to its peers.
Enterprise Value |
|
To determine if EnVVeno Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EnVVeno Medical's net worth research are outlined below:
| enVVeno Medical Corp had very high historical volatility over the last 90 days | |
| Net Loss for the year was (23.52 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| enVVeno Medical Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: enVVeno Medical Participates in the Virtual Investor Top 5 for 25 On-Demand Conference |
EnVVeno Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in enVVeno Medical Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EnVVeno Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of January 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 25th of January 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
EnVVeno Medical Target Price Consensus
EnVVeno target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. EnVVeno Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most EnVVeno analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand EnVVeno stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of enVVeno Medical Corp, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationEnVVeno Medical Target Price Projection
EnVVeno Medical's current and average target prices are 3.46 and 18.00, respectively. The current price of EnVVeno Medical is the price at which enVVeno Medical Corp is currently trading. On the other hand, EnVVeno Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
EnVVeno Medical Market Quote on 27th of February 2025
Target Price
Analyst Consensus On EnVVeno Medical Target Price
Know EnVVeno Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as EnVVeno Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading enVVeno Medical Corp backward and forwards among themselves. EnVVeno Medical's institutional investor refers to the entity that pools money to purchase EnVVeno Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hohimer Wealth Management, Llc | 2024-12-31 | 51.3 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 48.8 K | Squarepoint Ops Llc | 2024-12-31 | 47.9 K | State Street Corp | 2024-12-31 | 40.8 K | Blackrock Inc | 2024-12-31 | 40.6 K | Fermata Advisors, Llc | 2024-12-31 | 35.7 K | Virtu Financial Llc | 2024-12-31 | 28.5 K | Laird Norton Tyee Trust Co | 2024-12-31 | 25 K | Jane Street Group Llc | 2024-12-31 | 18.5 K | Kingdon Capital Management Llc | 2024-12-31 | 859.3 K | Nantahala Capital Management, Llc | 2024-12-31 | 596.9 K |
Follow EnVVeno Medical's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 61.9 M.Market Cap |
|
Project EnVVeno Medical's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.44) | (0.46) | |
| Return On Capital Employed | (0.61) | (0.58) | |
| Return On Assets | (0.44) | (0.46) | |
| Return On Equity | (0.59) | (0.61) |
When accessing EnVVeno Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures EnVVeno Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EnVVeno Medical's profitability and make more informed investment decisions.
Evaluate EnVVeno Medical's management efficiency
enVVeno Medical Corp has return on total asset (ROA) of (0.3728) % which means that it has lost $0.3728 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5877) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of February 2025, Return On Tangible Assets is likely to drop to -0.46. In addition to that, Return On Capital Employed is likely to grow to -0.58. At this time, EnVVeno Medical's Total Assets are very stable compared to the past year. As of the 27th of February 2025, Total Current Assets is likely to grow to about 56.7 M, while Non Current Assets Total are likely to drop about 1.8 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.38 | 3.55 | |
| Tangible Book Value Per Share | 3.38 | 3.55 | |
| Enterprise Value Over EBITDA | (2.19) | (2.30) | |
| Price Book Value Ratio | 1.23 | 1.29 | |
| Enterprise Value Multiple | (2.19) | (2.30) | |
| Price Fair Value | 1.23 | 1.29 | |
| Enterprise Value | 54.9 M | 57.7 M |
Leadership effectiveness at enVVeno Medical Corp is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnVVeno Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnVVeno Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnVVeno Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
EnVVeno Medical Corporate Filings
F4 | 3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 19th of November 2024 Other Reports | ViewVerify | |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 31st of October 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
EnVVeno Medical Earnings Estimation Breakdown
The calculation of EnVVeno Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of EnVVeno Medical is estimated to be -0.33 with the future projection ranging from a low of -0.33 to a high of -0.33. Please be aware that this consensus of annual earnings estimates for enVVeno Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.33 Lowest | Expected EPS | -0.33 Highest |
EnVVeno Medical Earnings Projection Consensus
Suppose the current estimates of EnVVeno Medical's value are higher than the current market price of the EnVVeno Medical stock. In this case, investors may conclude that EnVVeno Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and EnVVeno Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 1 | 76.5% | -0.35 | -0.33 | -1.29 |
EnVVeno Medical Earnings per Share Projection vs Actual
Actual Earning per Share of EnVVeno Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering enVVeno Medical Corp predict the company's earnings will be in the future. The higher the earnings per share of EnVVeno Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.EnVVeno Medical Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as EnVVeno Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of EnVVeno Medical should always be considered in relation to other companies to make a more educated investment decision.EnVVeno Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact EnVVeno Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-10-31 | 2024-09-30 | -0.33 | -0.35 | -0.02 | 6 | ||
2024-07-31 | 2024-06-30 | -0.36 | -0.31 | 0.05 | 13 | ||
2024-05-08 | 2024-03-31 | -0.4 | -0.31 | 0.09 | 22 | ||
2024-02-29 | 2023-12-31 | -0.46 | -0.36 | 0.1 | 21 | ||
2023-10-26 | 2023-09-30 | -0.48 | -0.45 | 0.03 | 6 | ||
2023-07-31 | 2023-06-30 | -0.49 | -0.58 | -0.09 | 18 | ||
2023-04-28 | 2023-03-31 | -0.48 | -0.57 | -0.09 | 18 | ||
2023-03-02 | 2022-12-31 | -0.57 | -0.55 | 0.02 | 3 | ||
2022-10-27 | 2022-09-30 | -0.52 | -0.54 | -0.02 | 3 | ||
2022-08-03 | 2022-06-30 | -0.33 | -0.63 | -0.3 | 90 | ||
2022-04-29 | 2022-03-31 | -0.29 | -0.47 | -0.18 | 62 | ||
2022-03-28 | 2021-12-31 | -0.33 | -0.94 | -0.61 | 184 | ||
2021-11-12 | 2021-09-30 | -0.34 | -0.26 | 0.08 | 23 | ||
2021-08-11 | 2021-06-30 | -0.34 | -0.28 | 0.06 | 17 | ||
2021-05-12 | 2021-03-31 | -0.34 | -0.48 | -0.14 | 41 | ||
2021-03-31 | 2020-12-31 | -0.98 | -2.46 | -1.48 | 151 | ||
2020-11-17 | 2020-09-30 | -1.25 | -1.25 | 0.0 | 0 | ||
2020-03-18 | 2019-12-31 | -3.25 | -3.25 | 0.0 | 0 | ||
2019-10-31 | 2019-09-30 | -3.5 | -2.5 | 1.0 | 28 | ||
2019-08-05 | 2019-06-30 | -0.11 | -0.13 | -0.02 | 18 | ||
2019-06-13 | 2019-03-31 | -0.27 | -0.13 | 0.14 | 51 | ||
2019-02-27 | 2018-12-31 | -0.28 | -0.28 | 0.0 | 0 | ||
2018-11-28 | 2018-09-30 | -0.68 | -0.13 | 0.55 | 80 | ||
2018-05-22 | 2018-03-31 | 0 | -0.11 | -0.11 | 0 | ||
2018-03-07 | 2017-12-31 | 0 | 0.02 | 0.02 | 0 | ||
2017-12-14 | 2017-09-30 | 0 | -0.21 | -0.21 | 0 | ||
2017-09-07 | 2017-06-30 | 0 | -0.12 | -0.12 | 0 |
EnVVeno Medical Corporate Management
| Andrew Cormack | Chief Officer | Profile | |
| Craig Glynn | Treasurer CFO | Profile | |
| Benedict MD | Chief States | Profile | |
| Sandy Prietto | Vice Marketing | Profile | |
| Robert Berman | CEO Director | Profile | |
| Marc MD | Senior Officer | Profile | |
| Hamed Alavi | Senior Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.